CONNECT WITH US
HealthTech

HealthTech

CDRH on hiring spree after significant staff losses, director says

MedTech Dive logo

Published on

Add as a preferred source on Google
CDRH on hiring spree after significant staff losses, director says

Dr. Michelle Tarver said the FDA’s device center is filling positions after losing large numbers of clinical reviewers and AI and digital health experts.

BOSTON — The Food and Drug Administration’s medical device center has lost a significant number of staff following massive cuts at the start of the Trump administration. The regulator is now looking to make up lost ground through a hiring push, Dr. Michelle Tarver, director of the Center for Devices and Radiological Health, said Wednesday at AdvaMed’s The MedTech Conference.

“We’ve had over the past year-plus about 22% attrition rates,” Tarver said.

Some areas have been affected more than others. The device center has lost up to 30% of clinical reviewers and a significant number of digital health and artificial intelligence specialists, the director said.

As a result, the device center has been on a recruiting tear.

Over the summer, the FDA’s acting chief of staff announced the agency has been authorized to hire 2,200 people. The figures did not include a breakdown for the different FDA centers. Tarver said the CDRH is still awaiting final orders, but the device center has hired more than 65 people in the building, exceeding its target of 63 people for fiscal year 2026 under the current medical device user fee amendments, or MDUFA.

“We have actually exceeded our hiring for fiscal year ‘26 under the MDUFA commitment, which is a herculean effort considering all the changes that have happened, as well as a testament to people recognizing how much that mission resonates with them,” Tarver said.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.